Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 CFO - YUMANITY THERAPEUTICS, INC. | pti-ex312_9.htm |
| EX-31.1 - EX-31.1 CEO - YUMANITY THERAPEUTICS, INC. | pti-ex311_7.htm |
| EX-23.1 - EX-23.1 PWC CONSENT - YUMANITY THERAPEUTICS, INC. | pti-ex231_8.htm |
| EX-10.21 - EX-10.21 MUNOZ EMPLOYMENT AGREEMENT - YUMANITY THERAPEUTICS, INC. | pti-ex1021_125.htm |
| EX-10.13 - EX-10.13 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY - YUMANITY THERAPEUTICS, INC. | pti-ex1013_126.htm |
| 10-K - 10-K - YUMANITY THERAPEUTICS, INC. | pti-10k_20171231.htm |
Exhibit 32.1
Certification Pursuant to
18 U.S.C. Section 1350
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 10-K of Proteostasis Therapeutics, Inc. (the “Company”) for the year ended December 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of her knowledge:
|
(1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
|
|
|
|
|
|
Date: March 14, 2018 |
|
|
|
/s/ Meenu Chhabra |
|
|
|
|
|
Meenu Chhabra |
|
|
|
|
|
President and Chief Executive Officer (Principal Executive Officer) |
In connection with the Annual Report on Form 10-K of Proteostasis Therapeutics, Inc. (the “Company”) for the year ended December 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of his knowledge:
|
(1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: March 14, 2018 |
|
|
|
/s/ Helen M. Boudreau |
|
|
|
|
|
Helen M. Boudreau |
|
|
|
|
|
Vice President of Finance, Controller and Assistant Treasurer (Principal Financial Officer and Principal Accounting Officer) |